-
Recent Posts
- Dementia-Friendly Communities Provision, Viewed as a Social Determinant of Health (JGCR / NHS England / WHO)
- International Perspectives on the Possible Impact of the COVID-19 Pandemic and Lockdown on Abuse of the Elderly (JGCR / American Journal of Geriatric Psychiatry / JAGS)
- Updates Relating to the Lancet Commission on Dementia Prevention, Intervention, and Care (Lancet / Alzheimer’s Research and Therapy / Alzheimer’s and Dementia)
- A Brief Review of How the COVID-19 Pandemic Relates to Elderly Care and Research (JGCR)
- Some Speculated / Potential Benefits of COVID-19 (JGCR / BBC Radio 4’s Rethink / BGS)
Archives
- September 2020
- August 2020
- June 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Journal of Alzheimer’s Disease
Unexpected Results From the Dementia and Physical Activity (DAPA) Trial? (Pharmacoeconomics Open / JAD)
Summary Previous research has suggested that physical exercise has the potential to slow the progression of dementia in people with pre-existing mild cognitive impairment through to moderate dementia. Evidence for the cost-effectiveness of structured physical activity programmes has been lacking, … Continue reading
Posted in Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Local Interest, Management of Condition, Models of Dementia Care, National, NHS, NIHR, Non-Pharmacological Treatments, Personalisation, Quick Insights, Statistics, UK, Universal Interest, Wolverhampton
Tagged 2gether NHS Foundation Trust, ADAS-Cog: Alzheimer’s Disease Assessment Scale - Cognitive Subscale, Ageing, Ageing and Dementia, Ageing Population, Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Berkshire Healthcare NHS Foundation Trust, Black Country Partnership NHS Foundation Trust, Centre for Rehabilitation Research in Oxford: University of Oxford, Centre for Statistics in Medicine: University of Oxford, Cost-Effectiveness, Cost-Effectiveness Analyses, Coventry and Warwickshire Partnership NHS Trust: Reference Costs, DAPA - Dementia and Physical Activity Trial, DAPA Trial, DAPA Trial Group, Dementia And Physical Activity (DAPA) Trial, Exercise, Exercise And Lifestyle For Older People, Exercise for Dementia, Exercise Medicine, Exercise Therapy, Exergaming, Gloucestershire Hospitals NHS Foundation Trust, Greater Manchester West Mental Health NHS Foundation Trust, Health Technology Assessment, Health Technology Assessment (HTA) Programme, Health Technology Assessments, Herefordshire, Incremental Net Monetary Benefits (INMBs), INMB: Incremental Net Monetary Benefit, Join Dementia Research, Journal of Alzheimer's Disease, Kings College London, Leicester Partnership NHS Trust, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), National Institute of Health Research (NIHR), NIHR Health Technology Assessment (HTA) Programme, NIHR HTA: Health Technology Assessment Programme, North East London Foundation Trust (NELFT), Northamptonshire Healthcare NHS Foundation Trust, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences: University of Oxford, Oxford University Hospitals NHS Foundation Trust, Pharmacoeconomics Open (Journal), Physical Activity, Physical Activity Programmes, Physical Exercise, Reducing Waste in Dementia Care, Reducing Waste in the NHS, Royal Devon and Exeter NHS Foundation Trust, Solent NHS Trust, UK National Institute of Health Research HTA Programme, University of London, University of Oxford, University of Warwick, Value of Quality Adjusted Life Years (QALYs), Warwick Clinical Trials Unit: University of Warwick, Warwick Medical School: University of Warwick
Leave a comment
Preventative Treatment to Reduce Risk of Alzheimer’s Disease, Using Non-Steroidal Anti-Inflammatory Drugs? (NHS Choices / Journal of Alzheimer’s Disease)
Summary A recent article suggests that use of nonsteroidal anti-inflammatory drugs (NSAIDs) might help to reduce the risk of developing Alzheimer’s Disease, if prescription were to be commenced years before clinical signs were to develop. An NHS Choices Behind the … Continue reading
Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Pharmacological Treatments, Quick Insights, Universal Interest
Tagged Aβ42, Alzheimer Disease Anti-Inflammatory Prevention, Alzheimer’s Disease Biomarkers, Amyloid Beta (Aβ42), Amyloid Beta Protein, Amyloid Cascade Inflammatory Hypothesis, Amyloid-β (Aβ), Amyloidogenic and Inflammatory Pathways, Aurin Biotech, Aurin Biotech Inc. Ltd. (Vancouver), ß-amyloid, Bazian, Behind the Headlines, Biomarkers, Canada, Critical Appraisals, Dementia Risk Reduction and Prevention, Dementia Saliva Testing (Pilot Study), Diagnosis of Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels, ELISA Method to Determine Aβ42 Levels in Saliva, Fluid Biomarker Analysis, Ibuprofen, Ibuprofen and the Reduced Risk of Alzheimer’s Disease Link, Inflammation, Journal of Alzheimer's Disease, Long-Term Ibuprofen Use, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Neuroinflammation, Non-Invasive Biomarkers, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), NSAIDS: Non-Steroidal Anti-Inflammatory Drugs, Preclinical Biomarkers in Alzheimer's Disease, Preventative Interventions, Prevention, Saliva Tests, Salivary Amyloid-β Protein 42 Levels, Salivary Biomarkers
Leave a comment
Systematic Review of Blood Biomarkers for Alzheimer’s Disease Onset and Progression (Journal of Alzheimer’s Disease)
Summary Blood-based protein biomarkers to predict the onset and progression of Alzheimer’s Disease (AD) would assist in timely diagnosis and would also be beneficial for clinical trials in helping with the selection of subjects for preventative trials. This systematic review … Continue reading
Posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Systematic Reviews, UK
Tagged AddNeuroMed (ANM), Alzheimer's Research UK, Apolipoprotein E, Aristotle University, Biological Networks Gene Ontology tool (BINGO), Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomedical Research Unit for Dementia: South London and Maudsley NHS Foundation, Blood Proteins as Biomarkers of Disease Research, Blood-Based Biomarkers, Candidate Blood Proteome Markers, Complement C3, Database for Annotation, Department of Neurobiology: Karolinska Institutet-Stockholm University, France, Gene Ontology (GO), Greece, INSERM, INSERM: University of Toulouse, Institute of Psychiatry: King's College London, Italy, α-1-antitrypsin, α-2-macroglobulin, Journal of Alzheimer's Disease, Karolinska Institutet, King's Health Partners (ARUK/DCR) Research Cohorts, Kings College London, Kuopio University Hospital, Kyoto Encyclopedia of Genes and Genomes (KEGG), Maudsley BRC Dementia Case Registry, Medical University of Lodz, NIHR Biomedical Research Centre for Mental Health, Non-Invasive Biomarkers, Plasma Biomarkers, Poland, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, SomaLogic (Boulder Colorado), SomaLogic's SOMAscan Proteomics, South London and Maudsley NHS Foundation, Sweden, University of Eastern Finland, University of Perugia, USA, Visualization and Integrated Discovery (DAVID)
Leave a comment
Cognitive and Neuroimaging Predictors of Progression from Mild Cognitive Impairment to Dementia (NHS Choices / Journal of Alzheimer’s Disease)
Summary The detection of pre-clinical Alzheimer’s Disease appears to be accomplished best by the use of a combination of information, taken from targeted neuroimaging and complementary neuropsychological assessments of cognitive functioning. This combination of approaches may be necessary in order to … Continue reading
Posted in Acute Hospitals, Community Care, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Patient Care Pathway, Quick Insights, Universal Interest
Tagged 1Institut Universitaire de Gériatrie de Montréal, Behind the Headlines, Canada, Canadian Institutes of Health Research, Canadian Institutes of Health Research (CIHR), Cortical Thickness, Cortical Thinning, Critical Appraisals, Detection of Incipient Dementia, Heart and Stroke Foundation of Canada, Hippocampal Volume, Institut Universitaire de Gériatrie de Montréal, Journal of Alzheimer's Disease, Magnetic Resonance Imaging (MRI), MCI: Mild Cognitive Impairment, Middle Frontal Gyri, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Montréal, MRI, MRI Brain Imaging, MRI Scans, Neuroimaging, Neuropsychological Measures, Progression of Mild Cognitive Impairment to Dementia, Right Anterior Cingulate, Transition from Cognitive Impairment to Dementia, Université de Montréal, White Matter Hyperintensities
Leave a comment